Development of Drugs for Cryptosporidium Infection

Tzipori, Saul R.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Allergy and Infectious Diseases (NIAID)
• Type: Research and Development Contracts (N01)
• Project #: N01AI025143-003
• Application #: 2295485
• Project Start: 1992-07-07
• Project End: 1997-07-06
• Budget Start: 1994-06-22
• Budget End: 1995-07-06
• Fiscal Year: 1994

Institution

• Name: Tufts University
• Department: Internal Medicine/Medicine
• Type: Schools of Medicine
• DUNS #: 604483045
• City: Boston
• State: MA
• Country: United States
• Zip Code: 02111

Publications

Carraway, M; Tzipori, S; Widmer, G (1997) A new restriction fragment length polymorphism from Cryptosporidium parvum identifies genetically heterogeneous parasite populations and genotypic changes following transmission from bovine to human hosts. Infect Immun 65:3958-60

Tzipori, S; Rand, W; Griffiths, J et al. (1994) Evaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulin. Clin Diagn Lab Immunol 1:450-63

Carraway, M; Widmer, G; Tzipori, S (1994) Genetic markers differentiate C. parvum isolates. J Eukaryot Microbiol 41:26S